Fulcrum Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 10.23 M | $48.08 M | 0.00% | 16.39% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 5.25 M | $24.68 M | 0.00% | 8.41% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 5.17 M | $24.30 M | -9.41% | 8.28% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 4.78 M | $22.46 M | 0.04% | 7.66% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 3.34 M | $15.69 M | 182.25% | 5.35% |
| VANGUARD GROUP INC | 02/11/2025 | 3.25 M | $15.27 M | -0.76% | 5.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 3.00 M | $14.10 M | 50.00% | 4.81% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.42 M | $6.67 M | -0.34% | 2.27% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.41 M | $6.63 M | 110.27% | 2.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.29 M | $6.09 M | -1.99% | 2.07% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 583,203 | $2.74 M | -23.03% | 0.93% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 542,258 | $2.55 M | -41.56% | 0.87% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 526,045 | $2.47 M | -7.58% | 0.84% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 452,100 | $2.12 M | -79.57% | 0.72% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 367,594 | $1.73 M | 176.84% | 0.59% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 343,600 | $1.61 M | -10.10% | 0.55% |
| SHAY CAPITAL LLC | 02/14/2025 | 301,464 | $1.42 M | 4.23% | 0.48% |
| BESSEMER GROUP INC | 02/13/2025 | 286,988 | $1.35 M | 0.00% | 0.46% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 285,491 | $1.34 M | -0.15% | 0.46% |
| EXOME ASSET MANAGEMENT LLC | 02/14/2025 | 283,599 | $1.33 M | 100.00% | 0.45% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 273,000 | $1.28 M | -50.98% | 0.44% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 238,000 | $1.12 M | 100.00% | 0.38% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 213,213 | $1.00 M | 100.00% | 0.34% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 200,096 | $940,452 | 166.79% | 0.32% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 196,248 | $922,366 | 251.69% | 0.31% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 172,158 | $809,143 | -2.27% | 0.28% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 169,549 | $796,880 | 0.00% | 0.27% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 169,542 | $796,847 | -37.69% | 0.27% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 144,942 | $681,227 | 58.90% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 141,873 | $666,806 | 2.25% | 0.23% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 140,000 | $658,000 | 100.00% | 0.22% |
| FIDUCIARY TRUST CO | 02/14/2025 | 136,555 | $641,809 | 0.00% | 0.22% |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 02/10/2025 | 130,693 | $614,257 | 100.00% | 0.21% |
| MATISSE CAPITAL | 01/24/2025 | 128,445 | $603,692 | 20.36% | 0.21% |
| BARCLAYS PLC | 02/13/2025 | 122,070 | $575,000 | -1.67% | 0.20% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 120,611 | $566,872 | 5.95% | 0.19% |
| MACKENZIE FINANCIAL CORP | 02/20/2025 | 118,025 | $554,718 | 412.53% | 0.19% |
| LMR PARTNERS LLP | 02/14/2025 | 112,500 | $528,750 | 100.00% | 0.18% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 111,812 | $525,516 | 100.00% | 0.18% |
| FMR LLC | 02/13/2025 | 90,465 | $425,186 | -94.75% | 0.15% |
| RHUMBLINE ADVISERS | 01/30/2025 | 88,607 | $416,446 | 1.60% | 0.14% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 86,085 | $404,600 | 272.66% | 0.14% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 83,428 | $392,000 | -1.18% | 0.13% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/11/2025 | 80,714 | $379,356 | -77.03% | 0.13% |
| RBF CAPITAL, LLC | 02/14/2025 | 80,506 | $378,378 | -24.14% | 0.13% |
| JPMORGAN CHASE & CO | 02/12/2025 | 79,120 | $371,864 | -57.73% | 0.13% |
| UBS GROUP AG | 02/14/2025 | 77,392 | $363,742 | -4.02% | 0.12% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 76,123 | $357,778 | 224.00% | 0.12% |
| HSBC HOLDINGS PLC | 02/14/2025 | 75,959 | $354,729 | 54.97% | 0.12% |
| NEBULA RESEARCH & DEVELOPMENT LLC | 02/14/2025 | 75,140 | $353,158 | -8.07% | 0.12% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Fulcrum Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 155 institutional investors and hedge funds held shares of Fulcrum Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.23 M
TCG Crossover Management, LLC: 5.25 M
BlackRock Funding, Inc. /DE: 5.17 M
Nantahala Capital Management, LLC: 4.78 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 3.34 M
VANGUARD GROUP INC: 3.25 M
82.74% of Fulcrum Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 55.70 M shares in the last 24 months. This purchase volume represents approximately $274.05 M in transactions.